Advertisement
For patients with type 2 diabetes

Improved Glycemic Control With Eradication of Hepatitis C

0
Improved glycemic control, reduced antidiabetic medication use with sustained virologic response
In a technologically advanced society

AMA: Doctors Should Make Sure Their Online Info Is Accurate

0
Speakers in educational session urge caution in online behavior
Hyperbaric oxygen therapy is increasingly being used

Hyperbaric Oxygen Therapy Increasingly Being Used

0
Hyperbaric therapy increasing for diabetic wounds, although it is not recommended by ADA
For patients with type 1 or type 2 diabetes

Insulin Degludec Linked to Reduced Rate of Hypoglycemia

0
Reduced rate of hypoglycemic episodes among patients with type 1 diabetes, type 2 diabetes
Market competition levels are associated with changes in the price of generic drugs

Market Competition Linked to Change in Generic Drug Prices

0
Price change of −31.7 percent for quadropoly and 47.4 percent for monopoly
Therapeutic inertia occurs in 19.1 percent of patients with type 2 diabetes with hemoglobin A1c ≥8 percent on two or more non-insulin antidiabetic drugs

Therapeutic Inertia in 19 Percent With T2DM, HbA1c ≥8 Percent

0
HbA1c values of 8.0 to 9.9, >10 percent, diabetes duration ≥20 years linked to tx intensification
Electronic cigarette smoking has the same deleterious effect on weight and metabolic parameters as traditional cigarettes

Comparable Metabolic Effects for E-Cigarettes, Smoking

0
Even without nicotine exposure, similar deleterious effects for e-cigarettes, traditional tobacco cigarettes

June 2017 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for June 2017. This roundup includes...
For children

Genetic, Environmental Exposure Tied to Islet Autoantibodies

0
Link for male sex; father, sibling as diabetic proband; weight at 12 months with insulin autoantibodies
Patients with remaining endogenous β-cell function after a decade of living with type 1 diabetes tend to have much higher levels of interleukin-35 than other patients with long-standing type 1 diabetes

T1DM Patients With Active β-Cell Function Differ Immunologically

0
Findings for patients with remaining endogenous β-cell function after 10 or more years of T1DM